COVID-19

  • A now-or-never moment for telehealth?

    A now-or-never moment for telehealth?

    Our CMO Dr. Andrew Hertler speaks with HFMA about the role of telehealth in oncology care today.

    Read External Article
  • Oncology Quickly Adapted for the Pandemic. Here are 5 Changes Worth Keeping

    Oncology Quickly Adapted for the Pandemic. Here are 5 Changes Worth Keeping

    Read External Article
  • ×

    First Name
    Last Name
    Company Name
    Thank you!
    Error - something went wrong!
  • A Conversation with Swedish Cancer Institute's Dr. Jeffery Ward on COVID-19's Impact on Oncology

    A Conversation with Swedish Cancer Institute's Dr. Jeffery Ward on COVID-19's Impact on Oncology

    Dr. Jeffery Ward, an Oncologist / Hematologist with Swedish Cancer Institute, discusses the initial measures to protect patients, planning for the return of deferred care, and impact of COVID-19.

    Watch Video
  • Will COVID-19 Spark a Long-Needed Conversation Around Value in Oncology?

    Will COVID-19 Spark a Long-Needed Conversation Around Value in Oncology?

    The pandemic has forced difficult trade-offs between cancer treatment and infection prevention. We also need to be willing to make hard decisions around value, our CMO writes.

    Read Article
  • Let's Go
  • On-Demand Webinar: Oncology in the Wake of COVID-19: The Lasting Impact on Cancer Care

    On-Demand Webinar: Oncology in the Wake of COVID-19: The Lasting Impact on Cancer Care

    Watch this on-demand webinar to explore the future of cancer care in a post COVID-19 world.

    Watch Webinar
  • The Impact of COVID-19 on Oncology Practices and the Delivery of Cancer Care: Insights from our Scientific Advisory Board Roundtable

    The Impact of COVID-19 on Oncology Practices and the Delivery of Cancer Care: Insights from our Scientific Advisory Board Roundtable

    Caring for a population that is highly vulnerable to COVID-19, oncology practices have had to rapidly adapt for the pandemic. Listen to key takeaways from how oncology practices are responding.

    Watch Video
  • Cancer Care During COVID-19: How Practices and Health Plans Can Navigate New Risks

    Cancer Care During COVID-19: How Practices and Health Plans Can Navigate New Risks

    Our CMO Dr. Andrew Hertler offers insights for minimizing patients' risk of COVID-19 when their cancer therapies cannot be delayed.

    Read Article
  • COVID-19 Resources for Providers and Health Plans

    COVID-19 Resources for Providers and Health Plans

    A compilation of infection prevention resources, regulatory updates and guidance for managing high-risk populations in this pandemic.

    Read Article
  • loading
    Loading More...